Aleafia Health Announces Second Quarter 2020 Results

“Our significant increase in medical cannabis sales and patient growth, coupled with much needed Cannabis 2.0 formats and dried flower products will see us continue to capture market in both the medical and adult-use markets.” CEO Geoffrey Benic Highlights $57.0M cash, cash equivalents and freely tradeable marketable securities $3.0 million positive adjusted EBITDA 44% increaseContinue reading “Aleafia Health Announces Second Quarter 2020 Results”

MariMed Reports Strong Second Quarter Results

NORWOOD, Mass., Aug. 11, 2020 (GLOBE NEWSWIRE) — MariMed Inc. (MRMD:OTCQX), a leading multi-state cannabis and hemp operator focused on health and wellness, today reported financial and operating results for the three and six months ended June 30, 2020. Second Quarter 2020 and YTD Financial Highlights: Core cannabis Revenues of $9.6 million in Q2, a 163% increaseContinue reading “MariMed Reports Strong Second Quarter Results”

Liberty Leaf to Acquire Nova Mentis Biotech Corp. – Liberty Leaf Augments Portfolio with Entrance into the Emerging Psilocybin Therapy Market

– Liberty Leaf Holdings Ltd. (CSE: LIB) (FSE: HN3P) (OTCPK: LIBFF) (“LIB” or the “Company”) is pleased to announce that it has entered into an agreement (the “Agreement”) with Nova Mentis Biotech Corp. (“NOVA”), pursuant to which LIB will acquire, by way of share exchange, 100 per cent of all of the issued and outstanding securitiesContinue reading “Liberty Leaf to Acquire Nova Mentis Biotech Corp. – Liberty Leaf Augments Portfolio with Entrance into the Emerging Psilocybin Therapy Market”

Emerald Health Therapeutics to Host 2020 First Quarter Financial Results Conference Call on Friday, June 19, 2020 at 10:30 AM ET

— Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) today announced that, further to its news release on April 29th, Emerald will report its financial results for the first quarter ended March 31, 2020, after the market close on Thursday, June 18, 2020. The company will host a conference call on Friday, June 19, 2020,Continue reading “Emerald Health Therapeutics to Host 2020 First Quarter Financial Results Conference Call on Friday, June 19, 2020 at 10:30 AM ET”

MediPharm Labs Closes $37.8 Million Private Placement

“excited about the global market opportunity and leveraging our multi-jurisdictional pharmaceutical-quality manufacturing platform in a nascent cannabis market.” MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE:MLZ) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, is pleased to announce that it has today closed a private placement with an institutional investorContinue reading “MediPharm Labs Closes $37.8 Million Private Placement”

Green Thumb Industries to Open Rise Chambersburg, Its 46th Retail Location, on June 8

“We are grateful to open another Rise™ location in Pennsylvania and to continue to create jobs during the ongoing COVID-19 crisis,” Green Thumb Industries Inc. (GTI) (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer packaged goods company and owner of Rise™ and Essence retail stores, today announced it will open Rise Chambersburg, its 46th retailContinue reading “Green Thumb Industries to Open Rise Chambersburg, Its 46th Retail Location, on June 8”

Aurora Cannabis to Strategically Enter the United States with Acquisition of Reliva, LLC A Market Leading Mass Retail CBD Platform

NYSE | TSX: ACB All Share Transaction – Immediately Accretive to Shareholders on an Adjusted EBITDA Basis Profitable Today, Reliva Adds Strategic Entry to the U.S. that is Aligned to Aurora’s Business Transformation Plan Adds Miguel Martin, Veteran International Consumer Packaged Goods Executive to Aurora Management Team Reliva Provides Aurora with Top Ranked Retail Hemp-Derived CBDContinue reading “Aurora Cannabis to Strategically Enter the United States with Acquisition of Reliva, LLC A Market Leading Mass Retail CBD Platform”